ScoreHaematology

CNS-IPI: CNS relapse risk in diffuse large B-cell lymphoma

Estimates the 2-year risk of central nervous system relapse or progression in DLBCL treated with R-CHOP.

Updated 31 October 2026

When to use it

Patients with DLBCL at diagnosis starting R-CHOP or similar, to decide on CNS work-up and prophylaxis.

What it needs

  • Age > 60 yearsYes or no
  • Serum LDH above the upper limit of normalYes or no
  • ECOG ≥ 2Yes or no
  • Ann Arbor stage III–IVYes or no
  • More than 1 extranodal siteYes or no
  • Kidney or adrenal involvementYes or no

The points for each answer and the automatic total are in the app.

How to interpret it

CNS-IPI score
ResultInterpretation
≤ 1Low risk: 2-year CNS relapse ≈ 0.6%
2–3Intermediate risk: 2-year CNS relapse ≈ 3.4%
≥ 4High risk: 2-year CNS relapse ≈ 10%

Practical tip

Nearly 90% of patients fall into low or intermediate risk (< 5%) and can be spared CNS work-up and prophylaxis.

2 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top